Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/RGNT/Capital expenditures

Regentis Biomaterials Ltd. (RGNT) Capital expenditures

Regentis Biomaterials Ltd. (RGNT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to RGNT

Source: SEC XBRL filings · For reference only · Not investment advice

More RGNT financial trends

RGNT RevenueRGNT Net incomeRGNT Net marginRGNT Gross profitRGNT Gross marginRGNT Operating incomeRGNT Operating marginRGNT Operating cash flowRGNT Free cash flowRGNT Return on equityRGNT Stock buybacksRGNT Dividends paidRGNT Total assetsRGNT Total liabilitiesRGNT Shareholders’ equityRGNT overview →